Found: 45
Select item for more details and to access through your institution.
A comparative study on the efficacies of gonadotropin-releasing hormone (GnRH) agonist and GnRH antagonist in neoadjuvant androgen deprivation therapy combined with transperineal prostate brachytherapy for localized prostate cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Prostate-specific antigen ‘bounce’ after permanent <sup>125</sup>I-implant brachytherapy in Japanese men: a multi-institutional pooled analysis.
- Published in:
- BJU International, 2009, v. 103, n. 8, p. 1064, doi. 10.1111/j.1464-410X.2008.08234.x
- By:
- Publication type:
- Article
Identification of SARS-CoV-2 M<sup>pro</sup> inhibitors containing P1' 4-fluorobenzothiazole moiety highly active against SARS-CoV-2.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-36729-0
- By:
- Publication type:
- Article
National survey of radiation oncologists' practice patterns regarding hormone-naïve prostate cancer with bone metastases.
- Published in:
- Japanese Journal of Clinical Oncology, 2020, v. 50, n. 10, p. 1188, doi. 10.1093/jjco/hyaa111
- By:
- Publication type:
- Article
Clinical Significance of Intraductal Carcinoma of the Prostate After High-Dose Brachytherapy With External Beam Radiation Therapy: A Single Institution Series and an Updated Meta-Analysis.
- Published in:
- Clinical Genitourinary Cancer, 2024, v. 22, n. 2, p. 149, doi. 10.1016/j.clgc.2023.10.005
- By:
- Publication type:
- Article
Skin reactions after breast-conserving therapy and prediction of late complications using physiological functions.
- Published in:
- Breast Cancer (13406868), 2000, v. 7, n. 2, p. 142, doi. 10.1007/BF02967446
- By:
- Publication type:
- Article
A novel central nervous system-penetrating protease inhibitor overcomes human immunodeficiency virus 1 resistance with unprecedented aM to pM potency.
- Published in:
- eLife, 2017, p. 1, doi. 10.7554/eLife.28020
- By:
- Publication type:
- Article
Design, Synthesis and X‐Ray Structural Studies of Potent HIV‐1 Protease Inhibitors Containing C‐4 Substituted Tricyclic Hexahydro‐Furofuran Derivatives as P2 Ligands.
- Published in:
- ChemMedChem, 2022, v. 17, n. 9, p. 1, doi. 10.1002/cmdc.202200058
- By:
- Publication type:
- Article
Potent HIV‐1 Protease Inhibitors Containing Carboxylic and Boronic Acids: Effect on Enzyme Inhibition and Antiviral Activity and Protein‐Ligand X‐ray Structural Studies.
- Published in:
- ChemMedChem, 2019, v. 14, n. 21, p. 1863, doi. 10.1002/cmdc.201900508
- By:
- Publication type:
- Article
Front Cover: Design of Highly Potent, Dual‐Acting and Central‐Nervous‐System‐Penetrating HIV‐1 Protease Inhibitors with Excellent Potency against Multidrug‐Resistant HIV‐1 Variants (ChemMedChem 8/2018).
- Published in:
- ChemMedChem, 2018, v. 13, n. 8, p. 762, doi. 10.1002/cmdc.201800226
- By:
- Publication type:
- Article
Design of Highly Potent, Dual‐Acting and Central‐Nervous‐System‐Penetrating HIV‐1 Protease Inhibitors with Excellent Potency against Multidrug‐Resistant HIV‐1 Variants.
- Published in:
- ChemMedChem, 2018, v. 13, n. 8, p. 803, doi. 10.1002/cmdc.201700824
- By:
- Publication type:
- Article
Genetic Evidence of Transmission of Human T Cell Lymphotropic Virus Type 1 between Spouses.
- Published in:
- Journal of Infectious Diseases, 2002, v. 185, n. 5, p. 691, doi. 10.1086/339002
- By:
- Publication type:
- Article
Correction to: Comparison of outcomes in high‑risk prostate cancer patients treated with low‑/high‑dose‑rate brachytherapy plus external beam radiotherapy.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Clinical characteristics of secondary bladder cancer developing after low-/high-dose-rate brachytherapy to treat localized prostate cancer.
- Published in:
- International Journal of Clinical Oncology, 2023, v. 28, n. 9, p. 1200, doi. 10.1007/s10147-023-02383-1
- By:
- Publication type:
- Article
The prognostic significance of the clinical T stage and Grade Group in patients with locally advanced prostate cancer treated via high-dose-rate brachytherapy and external beam radiation.
- Published in:
- International Journal of Clinical Oncology, 2023, v. 28, n. 8, p. 1092, doi. 10.1007/s10147-023-02359-1
- By:
- Publication type:
- Article
Comparison of outcomes in high-risk prostate cancer patients treated with low-/high-dose-rate brachytherapy plus external beam radiotherapy.
- Published in:
- International Journal of Clinical Oncology, 2023, v. 28, n. 5, p. 698, doi. 10.1007/s10147-023-02314-0
- By:
- Publication type:
- Article
Prognostic value of PSA bounce after definitive radiotherapy revisited.
- Published in:
- International Journal of Clinical Oncology, 2022, v. 27, n. 2, p. 411, doi. 10.1007/s10147-021-02053-0
- By:
- Publication type:
- Article
How long is long enough to secure disease control after low-dose-rate brachytherapy in combination with other modalities in intermediate-risk, localized prostate cancer?
- Published in:
- International Journal of Clinical Oncology, 2022, v. 27, n. 1, p. 184, doi. 10.1007/s10147-021-02040-5
- By:
- Publication type:
- Article
Nationwide Japanese Prostate Cancer Outcome Study of Permanent Iodine-125 Seed Implantation (J-POPS): first analysis on survival.
- Published in:
- International Journal of Clinical Oncology, 2018, v. 23, n. 6, p. 1148, doi. 10.1007/s10147-018-1309-0
- By:
- Publication type:
- Article
Nationwide Japanese Prostate Cancer Outcome Study of Permanent Iodine-125 Seed Implantation (J-POPS).
- Published in:
- International Journal of Clinical Oncology, 2015, v. 20, n. 2, p. 375, doi. 10.1007/s10147-014-0704-4
- By:
- Publication type:
- Article
Results of central pathology review of prostatic biopsies in a contemporary series from a phase III, multicenter, randomized controlled trial ( SHIP0804).
- Published in:
- Pathology International, 2015, v. 65, n. 4, p. 177, doi. 10.1111/pin.12260
- By:
- Publication type:
- Article
The identification of ᴅ-tryptophan as a bioactive substance for postembryonic ovarian development in the planarian Dugesia ryukyuensis.
- Published in:
- Scientific Reports, 2017, p. 45175, doi. 10.1038/srep45175
- By:
- Publication type:
- Article
Differences in sex hormone recovery profile after cessation of 12‐week gonadotropin‐releasing hormone antagonist versus agonist therapy.
- Published in:
- Andrology, 2022, v. 10, n. 2, p. 270, doi. 10.1111/andr.13107
- By:
- Publication type:
- Article
Radiotherapy after radical prostatectomy for prostate cancer: clinical outcomes and factors influencing biochemical recurrence.
- Published in:
- Irish Journal of Medical Science, 2023, v. 192, n. 6, p. 2663, doi. 10.1007/s11845-023-03356-z
- By:
- Publication type:
- Article
The impact of multidisciplinary approaches on the outcomes of olfactory neuroblastoma treated with postoperative radiotherapy.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 5, p. 1, doi. 10.1002/cam4.6943
- By:
- Publication type:
- Article
Do androgen deprivation and the biologically equivalent dose matter in low-dose-rate brachytherapy for intermediate-risk prostate cancer?
- Published in:
- Cancer Medicine, 2016, v. 5, n. 9, p. 2314, doi. 10.1002/cam4.820
- By:
- Publication type:
- Article
Human Neutrophil Elastase Induce Interleukin-10 Expression in Peripheral Blood Mononuclear Cells through Protein Kinase C Theta/Delta and Phospholipase Pathways.
- Published in:
- Cell Journal (Yakhteh), 2016, v. 17, n. 4, p. 692
- By:
- Publication type:
- Article
Trimodal therapy with high-dose-rate brachytherapy and hypofractionated external beam radiation combined with long-term androgen deprivation for unfavorable-risk prostate cancer.
- Published in:
- Strahlentherapie und Onkologie, 2021, v. 197, n. 11, p. 976, doi. 10.1007/s00066-021-01784-3
- By:
- Publication type:
- Article
Patients with PSA below 0.2 ng/mL at 8 years post high‐dose‐rate brachytherapy have an extremely low risk of subsequent recurrence.
- Published in:
- International Journal of Urology, 2023, v. 30, n. 12, p. 1147, doi. 10.1111/iju.15289
- By:
- Publication type:
- Article
Salvage partial brachytherapy for prostate cancer recurrence after primary brachytherapy.
- Published in:
- International Journal of Urology, 2014, v. 21, n. 6, p. 572, doi. 10.1111/iju.12373
- By:
- Publication type:
- Article
Mid-term outcome of permanent prostate iodine-125 brachytherapy in Japanese patients.
- Published in:
- International Journal of Urology, 2014, v. 21, n. 5, p. 473, doi. 10.1111/iju.12347
- By:
- Publication type:
- Article
Single atom changes in newly synthesized HIV protease inhibitors reveal structural basis for extreme affinity, high genetic barrier, and adaptation to the HIV protease plasticity.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-65993-z
- By:
- Publication type:
- Article
Pulmonary Metastases After Low-Dose-Rate Brachytherapy for Localized Prostate Cancer.
- Published in:
- Korean Journal of Urology, 2014, v. 55, n. 5, p. 309, doi. 10.4111/kju.2014.55.5.309
- By:
- Publication type:
- Article
Evaluation of rectal bleeding factors associated with prostate brachytherapy.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Results of a dummy run of postimplant dosimetry between multi-institutional centers in prostate brachytherapy with 125I seeds.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Evaluation of interobserver differences in postimplant dosimetry following prostate brachytherapy and the efficacy of CT/MRI fusion imaging.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Long‐term outcomes of radical prostatectomy versus low‐dose‐rate brachytherapy in patients with intermediate‐risk prostate cancer: Propensity score matched comparison.
- Published in:
- Prostate, 2023, v. 83, n. 3, p. 135, doi. 10.1002/pros.24445
- By:
- Publication type:
- Article
Long‐term outcomes of radical prostatectomy versus low‐dose‐rate brachytherapy in patients with intermediate‐risk prostate cancer: Propensity score matched comparison.
- Published in:
- Prostate, 2023, v. 83, n. 2, p. 135, doi. 10.1002/pros.24445
- By:
- Publication type:
- Article
Clinical significance of unfavorable findings in intermediate‐risk prostate cancer patients for predicting treatment outcomes after contemporary, dose‐escalated multimodal radiotherapy.
- Published in:
- Prostate, 2022, v. 82, n. 4, p. 433, doi. 10.1002/pros.24289
- By:
- Publication type:
- Article
Design, Synthesis, Biological Evaluation, and X-ray Studies of HIV-1 Protease Inhibitors with Modified P2′ Ligands of Darunavir.
- Published in:
- ChemMedChem, 2017, v. 12, n. 23, p. 1942, doi. 10.1002/cmdc.201700614
- By:
- Publication type:
- Article
Design of gem-Difluoro- bis-Tetrahydrofuran as P2 Ligand for HIV-1 Protease Inhibitors to Improve Brain Penetration: Synthesis, X-ray Studies, and Biological Evaluation.
- Published in:
- ChemMedChem, 2015, v. 10, n. 1, p. 107, doi. 10.1002/cmdc.201402358
- By:
- Publication type:
- Article
Cover Picture: Probing Multidrug-Resistance and Protein-Ligand Interactions with Oxatricyclic Designed Ligands in HIV-1 Protease Inhibitors (ChemMedChem 11/2010).
- Published in:
- ChemMedChem, 2010, v. 5, n. 11, p. 1797, doi. 10.1002/cmdc.201090049
- By:
- Publication type:
- Article
Probing Multidrug-Resistance and Protein-Ligand Interactions with Oxatricyclic Designed Ligands in HIV-1 Protease Inhibitors.
- Published in:
- ChemMedChem, 2010, v. 5, n. 11, p. 1850, doi. 10.1002/cmdc.201000318
- By:
- Publication type:
- Article
Efficacy of intensity-modulated radiation therapy for optic nerve sheath meningioma.
- Published in:
- Graefe's Archive of Clinical & Experimental Ophthalmology, 2019, v. 257, n. 10, p. 2297, doi. 10.1007/s00417-019-04424-w
- By:
- Publication type:
- Article
Transperineal prostate brachytherapy, using I-125 seed with or without adjuvant androgen deprivation, in patients with intermediate-riskprostate cancer: study protocol for a phase III, multicenter, randomized, controlled trial.
- Published in:
- BMC Cancer, 2010, v. 10, p. 572, doi. 10.1186/1471-2407-10-572
- By:
- Publication type:
- Article